Bromley Tailored Dispensing Service

Tender description

The Tailored Dispensing Service (TDS) was commissioned in 2018, through an AQP exercise and contracts were awarded for 3 years with an option to extend for 2 further years, which has now been enacted. In order to access the TDS service, a referral is sent to the TDS pharmacy from the Bromley Medicine Optimisation Service (BMOS). BMOS will have received a referral from a GP, hospital, community service, or other member of health or social care staff, who feel that their patient would benefit from having a reasonable adjustment aid dispensed. BMOS comprises of a holistic assessment, usually in the patient's own home, of the patient's medicines routine to identify and address medicines compliance issues. The Bromley TDS is provided by 40 community pharmacies. The contract is activity and defined tariff based. The annual contract value is £308,000. This value will be inclusive of all activity, consumables, tariffs, and all associated management fees for both the Lead Provider and the TDS Contractors The TDS currently provide a service that: • Supports patients to manage their own medicines and maintain independence. • Improves patients' understanding of their medicines and improve adherence. • Undertakes clinical medication review of patients identified as having a medicines-related problem. • Reduces the number of inappropriate drugs prescribed using evidence-based tools. • Reduces the number of adverse drug events experienced. • Reduces medicines waste. • Works collaboratively with other health and social care professionals to support and implement personalised tailored interventions for individual patient needs. • Continuously works with the ICB and social care to develop and implement guidance/policies on medicines administration support. • Reduces the risks of harm caused by medicine regimens or inadvertent reconciliation errors. This VEAT is to inform the market of the ICB's intention to direct award a contract to the South East London Community Pharmacy Fed. The Fed is to provide a management role and will sub-contract to individual community pharmacies, ensuring continuity of current service provision and providing an opportunity for new TDS providers to deliver services as a sub-contractor to the South East London Community Pharmacy Fed. Lot 1: The Tailored Dispensing Service (TDS) was commissioned in 2018, through an AQP exercise and contracts were awarded for 3 years with an option to extend for 2 further years, which has now been enacted. In order to access the TDS service, a referral is sent to the TDS pharmacy from the Bromley Medicine Optimisation Service (BMOS). BMOS will have received a referral from a GP, hospital, community service, or other member of health or social care staff, who feel that their patient would benefit from having a reasonable adjustment aid dispensed. BMOS comprises of a holistic assessment, usually in the patient's own home, of the patient's medicines routine to identify and address medicines compliance issues. The Bromley TDS is provided by 40 community pharmacies. The contract is activity and defined tariff based. The annual contract value is £308,000. This value will be inclusive of all activity, consumables, tariffs, and all associated management fees for both the Lead Provider and the TDS Contractors The TDS currently provide a service that: • Supports patients to manage their own medicines and maintain independence. • Improves patients' understanding of their medicines and improve adherence. • Undertakes clinical medication review of patients identified as having a medicines-related problem. • Reduces the number of inappropriate drugs prescribed using evidence-based tools. • Reduces the number of adverse drug events experienced. • Reduces medicines waste. • Works collaboratively with other health and social care professionals to support and implement personalised tailored interventions for individual patient needs. • Continuously works with the ICB and social care to develop and implement guidance/policies on medicines administration support. • Reduces the risks of harm caused by medicine regimens or inadvertent reconciliation errors. This VEAT is to inform the market of the ICB's intention to direct award a contract to the South East London Community Pharmacy Fed. The Fed is to provide a management role and will sub-contract to individual community pharmacies, ensuring continuity of current service provision and providing an opportunity for new TDS providers to deliver services as a sub-contractor to the South East London Community Pharmacy Fed.